+56 9 5758 3832 info@innovacell.cl
  • Instagram
  • Instagram
Innovacell
  • Home
  • Quienes Somos
  • Equipo
  • Procedimientos
  • Evidencias
  • Publicaciones
  • Contáctanos
Seleccionar página

Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cells Induce a Switch from Classical to Atypical Symptoms in Experimental Autoimmune Encephalomyelitis (EAE).

por filla | May 9, 2022 | Ana Maria Vega L.

Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cells Induce a Switch from Classical to Atypical Symptoms in Experimental Autoimmune Encephalomyelitis (EAE). Stem Cells Int. 2015; 2015:140170. doi: 10.1155/2015/140170. AbstractPotent...

Overexpression of Glutamate Decarboxylase In Mesenchymal Stem Cells Enhances Their Immunosuppressive Properties And Increases GABA And Nitric Oxide Levels.

por filla | May 9, 2022 | Ana Maria Vega L.

Overexpression of Glutamate Decarboxylase In Mesenchymal Stem Cells Enhances Their Immunosuppressive Properties And Increases GABA And Nitric Oxide Levels. PLoS One. 2016 Sep 23;11(9):e0163735. doi: 10.1371/journal.pone.0163735. AbstractThe neurotransmitter GABA has...

Toll-like receptor 3 pre-conditioning increase the therapeutic efficacy of umbilical cord mesenchymal stem cells in a DSS-induced colitis mouse model.

por filla | May 9, 2022 | Ana Maria Vega L.

Toll-like receptor 3 pre-conditioning increase the therapeutic efficacy of umbilical cord mesenchymal stem cells in a DSS-induced colitis mouse model. Cytotherapy, 2016; 18: 630–641 AbstractBackground aims: Immunomodulatory properties of human umbilical cord-derived...

Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.

por filla | May 9, 2022 | Ana Maria Vega L.

Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE. Stem Cell Res Ther. 2016 Oct 10;7(1):150. AbstractBackground: Recently, it has been observed that mesenchymal stem cells (MSCs) can modulate their...

Gilz-Activin A as a Novel Signaling Axis Orchestrating Mesenchymal Stem Cell and Th17 Cell Interplay.

por filla | May 9, 2022 | Ana Maria Vega L.

Gilz-Activin A as a Novel Signaling Axis Orchestrating Mesenchymal Stem Cell and Th17 Cell Interplay. Theranostics. 2018; 8(3): 846–859.Published online 2018 Jan 1. doi: 10.7150/thno.21793. AbstractMesenchymal stem cells (MSC) are highly immunosuppressive cells able...

IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.

por filla | May 9, 2022 | Ana Maria Vega L.

IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis. Front. Immunol., 30 April 2018. https://doi.org/10.3389/fimmu.2018.00802. AbstractThe therapeutic effect of mesenchymal stem cells...
« Entradas más antiguas

Recent Posts

  • A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases. 
  • Comparative study of the neural differentiation capacity of mesenchymal stromal cells from different tissue sources: An approach for their use in neural regeneration therapies.
  • Stem Cell Therapy in Refractory Perineal Crohn’s Disease: Long-term Follow-up.
  • Cell therapy for cartilage defects of the hip.
  • Mesenchymal stem cell therapy in the treatment of hip osteoarthritis.

Recent Comments

No hay comentarios que mostrar.
  • Instagram